We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Necrotising otitis externa: the increasing financial burden on the National Health Service.
- Authors
Godbehere, J; Hutson, K H; Watson, G J
- Abstract
Objective: Necrotising otitis externa is increasingly being seen and treated within the UK. The aim of this study was to explore the potential cost of a cohort of patients with necrotising otitis externa presenting to a single tertiary NHS trust. Method: This was a retrospective study with data from 14 patients with confirmed necrotising otitis externa who were treated, monitored, discharged or who died between October 2016 and November 2018. Direct costs using the tariffs from the 2018 to 2019 financial year included in-patient stay, imaging, peripheral inserted central catheter line cost, ENT and out-patient parenteral antibiotic therapy visits and antimicrobial duration. Results: The mean cost of treatment per patient was £17 615 (range, £9407 to £38 230) with an extreme outlier costing more than £122 000. Conclusion: Awareness and education at a primary care level and research into robust imaging to aid termination of treatment may lower costs in the future by catching pathology early and reducing treatment duration.
- Subjects
OTITIS externa; INTRAVENOUS therapy; PERIPHERALLY inserted central catheters; MEDICAL care costs; TERTIARY care; RETROSPECTIVE studies; TREATMENT duration; NATIONAL health services; HOSPITAL care; LONGITUDINAL method
- Publication
Journal of Laryngology & Otology, 2022, Vol 136, Issue 8, p730
- ISSN
0022-2151
- Publication type
Article
- DOI
10.1017/S0022215121003443